Qiagen squeezes into Schuldschein market

Flaming Schuldschein Fotolia 230x15
By Silas Brown
11 May 2017

Dutch biotechnology firm Qiagen has launched a tightly priced €150m dual currency Schuldschein, with investors treating the Germany-headquartered firm as a domestic issuer.

Arrangers BayernLB, BNP ParibasHSBC and UniCredit are offering investors four, five and seven year tranches, in either euros or dollars. There is also a 10 year tranche in euros.

Price ranges are 90bp-100bp over mid-swaps or Libor for Qiagen’s four year dollar fixed and floating debt, 100bp-110bp for five ...

Please take a trial or subscribe to access this content.

Contact our subscriptions team to discuss your access: subs@globalcapital.com

Or sign up for a trial to gain full access to the entire site for a limited period.

Free Trial

Corporate access

To discuss GlobalCapital access for your entire department or company please contact our subscriptions sales team at: subs@globalcapital.com or find out more online here.